As shown in Fig. 6G, the expression of HLA-F was downregulated in the high-risk group, whereas, the expression of HLA-DQB2 was upregulated in the high-risk group, indicating that this possibly led to tumor immune evasion (P-value < 0.05). The gene discussed is HLA-DQB2; the disease is neoplasm.